FMC reported a more profitable Q4 without any restrucuring costs, which we had expected to clean up the company. The consensus was broadly met. However, 2019 will be a more challenging year due to investments in the future and the next cost-cutting programme kicking in into the one still running. The higher dividend and the share buyback programme make shareholders happy (Fresenius is the single largest one!) but leave us puzzled.
20 Feb 2019
A bright Q4, but no sunny 2019
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
A bright Q4, but no sunny 2019
Fresenius Medical Care AG (FME:WBO) | 0 0 0.7% | Mkt Cap: 26,769m
- Published:
20 Feb 2019 -
Author:
Martin Schnee -
Pages:
4
FMC reported a more profitable Q4 without any restrucuring costs, which we had expected to clean up the company. The consensus was broadly met. However, 2019 will be a more challenging year due to investments in the future and the next cost-cutting programme kicking in into the one still running. The higher dividend and the share buyback programme make shareholders happy (Fresenius is the single largest one!) but leave us puzzled.